To further determine whether LukS-PV inhibited the proliferation of HCC cells through Wnt/β-catenin signaling, HCC cells were pretreated with Wnt3a (Wnt/β-catenin signaling agonist) stimulation and then treated with LukS-PV. Here, WNT3A is linked to hepatocellular carcinoma.